Rubicon Research IPO Proceeds Monitoring Report for Quarter Ended Sep'26
Rubicon Research Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 10:48 pm
Rubicon Research IPO Proceeds Monitoring Report for Quarter Ended Sep'26 India Ratings reported no deviations from stated IPO objects for Rubicon Research for the quarter ended 30th Sep'26. Out of total fresh issue proceeds of INR 5,000.00 Mn, the company has utilized cumulative proceeds, leaving an unutilized balance of INR 670.93 Mn deployed in fixed deposits (INR 638.60 Mn) and escrow accounts (INR 32.33 Mn). The Board extended the proceeds utilization timeline by one year to 31st Mar'27. Total issue size was INR 13,775.00 Mn, including an offer for sale of INR 8,775.00 Mn.
Original exchange filing (PDF)
More announcements from Rubicon Research Ltd
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 (SEBI Regulations) w.r.t update on the Scheme of Merger between Rubicon Research Ltd and KIA Health Tech Pvt Ltd 路 14 Nov 2026
- Transcript of Earnings Call -Q2 - FY 2026-27 路 12 Nov 2026
- Audio Recording of Earnings confrence call for the Quarter ended 30th September, 2026 路 06 Nov 2026
- Investor Presentation for Q2 2026-27 路 05 Nov 2026
- Rubicon Research Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of the Board Meeting held on November 5, 2026 路 05 Nov 2026
- Grant of Stock Options under Rubicon Research LImited Stock Option Plan 2026 路 05 Nov 2026
- Outcome of USFDA Inspection of Rubicon Research Ltd Manufactiring Facility at Ambernath, India 路 30 Oct 2026
